Continuation vs. discontinuation of bDMARDs during the perioperative period

by Wolters Kluwer HealthCredit: Pixabay/CC0 Public DomainFor patients with rheumatic arthritis and other chronic inflammatory diseases, discontinuing biologic disease-modifying anti-rheumatic dru

Updated on: June 26,2024

Continuation vs. discontinuation of bDMARDs during the perioperative period

by Wolters Kluwer HealthCredit: Pixabay/CC0 Public DomainFor patients with rheumatic arthritis and other chronic inflammatory diseases, discontinuing biologic disease-modifying anti-rheumatic dru

Updated on:June 26,2024

Smokers with rheumatoid arthritis face extra barriers to quitting

by University of OtagoSmokers who suffer from Rheumatoid Arthritis (RA) may need more targeted support to successfully quit a habit that will likely worsen their disease, latest University of Ota

Updated on: March 24,2024

Smokers with rheumatoid arthritis face extra barriers to quitting

by University of OtagoSmokers who suffer from Rheumatoid Arthritis (RA) may need more targeted support to successfully quit a habit that will likely worsen their disease, latest University of Ota

Updated on:March 24,2024

Researchers discover potential new approach to treating psoriatic joint inflammation

by UC DavisCredit: CC0 Public DomainAn international team of researchers, led by UC Davis Health, has developed a new therapeutic approach to treating psoriatic arthritis, a chronic inflammatory

Updated on: June 17,2024

Researchers discover potential new approach to treating psoriatic joint inflammation

by UC DavisCredit: CC0 Public DomainAn international team of researchers, led by UC Davis Health, has developed a new therapeutic approach to treating psoriatic arthritis, a chronic inflammatory

Updated on:June 17,2024

Immune cell responses in COVID-19 patients far from optimal

by Doherty Institute for Infection and ImmunityCredit: Thiago Lazarino from PixabayMelbourne researchers have discovered that killer T cells, key immune cells in fighting viral infections, are present

Updated on: April 10,2024

Immune cell responses in COVID-19 patients far from optimal

by Doherty Institute for Infection and ImmunityCredit: Thiago Lazarino from PixabayMelbourne researchers have discovered that killer T cells, key immune cells in fighting viral infections, are present

Updated on:April 10,2024

Severe reaction to pneumococcal vaccines in patients with CAPS

(HealthDay)—Pneumococcal vaccines can trigger a severe local and systemic inflammatory reaction in patients with cryopyrin-associated periodic syndromes (CAPS), according to a study published in the F

Updated on: April 17,2024

Severe reaction to pneumococcal vaccines in patients with CAPS

(HealthDay)—Pneumococcal vaccines can trigger a severe local and systemic inflammatory reaction in patients with cryopyrin-associated periodic syndromes (CAPS), according to a study published in the F

Updated on:April 17,2024

Omega 3 fatty acids may reduce bacterial lung infections associated with COPD

by Suzanne Pallo,University of Rochester Medical CenterCompounds derived from omega-3 fatty acids – like those found in salmon – might be the key to helping the body combat lung infections, acco

Updated on: April 20,2024

Omega 3 fatty acids may reduce bacterial lung infections associated with COPD

by Suzanne Pallo,University of Rochester Medical CenterCompounds derived from omega-3 fatty acids – like those found in salmon – might be the key to helping the body combat lung infections, acco

Updated on:April 20,2024

PFAS can suppress white blood cell's ability to destroy invaders

by Tracey Peake,North Carolina State UniversityPFASs used in this study. Names and structures of the PFASs used in this study. Vendors and CAS-RN numbers are provided in Table 1. Chemical struct

Updated on: April 20,2024

PFAS can suppress white blood cell's ability to destroy invaders

by Tracey Peake,North Carolina State UniversityPFASs used in this study. Names and structures of the PFASs used in this study. Vendors and CAS-RN numbers are provided in Table 1. Chemical struct

Updated on:April 20,2024

Poverty tied to worse functional status in rheumatoid arthritis

(HealthDay)—Worse functional status and increased probability of functional decline are seen for patients with rheumatoid arthritis (RA) with lower socioeconomic status (SES), according to a study pub

Updated on: June 01,2024

Poverty tied to worse functional status in rheumatoid arthritis

(HealthDay)—Worse functional status and increased probability of functional decline are seen for patients with rheumatoid arthritis (RA) with lower socioeconomic status (SES), according to a study pub

Updated on:June 01,2024

How B cells recognize new variants of SARS-CoV-2

by Dr. Jan Grabowski, TWINCORE - Zentrum für Experimentelle und Klinische InfektionsforschungThe first author of the study, Dr Matthias Bruhn, in the lab Credit: TWINCORE/GrabowskiB cells are part of

Updated on: April 28,2024

How B cells recognize new variants of SARS-CoV-2

by Dr. Jan Grabowski, TWINCORE - Zentrum für Experimentelle und Klinische InfektionsforschungThe first author of the study, Dr Matthias Bruhn, in the lab Credit: TWINCORE/GrabowskiB cells are part of

Updated on:April 28,2024

Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is in

Updated on: June 01,2024

Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is in

Updated on:June 01,2024

1 billion people worldwide will suffer from arthritis by 2050

by Cara MurezThe degenerative joint disease osteoarthritis affects 15% of the global population over age 30, so by 2050 that could be nearly 1 billion people, researchers say.Living longer and obesity

Updated on: May 08,2024

1 billion people worldwide will suffer from arthritis by 2050

by Cara MurezThe degenerative joint disease osteoarthritis affects 15% of the global population over age 30, so by 2050 that could be nearly 1 billion people, researchers say.Living longer and obesity

Updated on:May 08,2024

Going all the way: Scientists prove that inhaled vaccines offer better protection and immunity than nasal sprays

by McMaster UniversityMichael D'Agostino demonstrates the aerosol delivery method, which in this study was done on animal models. Credit: McMaster UniversityMcMaster University scientists who

Updated on: May 08,2024

Going all the way: Scientists prove that inhaled vaccines offer better protection and immunity than nasal sprays

by McMaster UniversityMichael D'Agostino demonstrates the aerosol delivery method, which in this study was done on animal models. Credit: McMaster UniversityMcMaster University scientists who

Updated on:May 08,2024